These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37364064)

  • 1. NESFATIN-1 ACTIVITY IN THE BLOOD SERUM IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN AGAINST THE BACKGROUND OF TYPE 2 DIABETES MELLITUS AND OBESITY.
    Borovyk KM; Kadykova OI; Ryndina NG; Babadzhan VD; Yermak OS
    Wiad Lek; 2023; 76(5 pt 2):1141-1145. PubMed ID: 37364064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saxagliptin Upregulates Nesfatin-1 Secretion and Ameliorates Insulin Resistance and Metabolic Profiles in Type 2 Diabetes Mellitus.
    Chen K; Zhuo T; Wang J; Mei Q
    Metab Syndr Relat Disord; 2018 Sep; 16(7):336-341. PubMed ID: 29912623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus.
    Aslan M; Celik O; Celik N; Turkcuoglu I; Yilmaz E; Karaer A; Simsek Y; Celik E; Aydin S
    Endocrine; 2012 Jun; 41(3):424-9. PubMed ID: 22203468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nesfatin-1 levels in patients with different glucose tolerance levels.
    Algul S; Ozkan Y; Ozcelik O
    Physiol Res; 2016 Dec; 65(6):979-985. PubMed ID: 27539099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus.
    Liu F; Yang Q; Gao N; Liu F; Chen S
    J Diabetes Res; 2014; 2014():128014. PubMed ID: 24995340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NESFATIN-1 ACTIVITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PREDIABETES, TYPE 2 DIABETES].
    Kovalyova O; Ashcheulova T; Demydenko A; Vizir M; Kochubiei O
    Georgian Med News; 2017 Feb; (263):44-49. PubMed ID: 28452726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.
    Ding S; Qu W; Dang S; Xie X; Xu J; Wang Y; Jing A; Zhang C; Wang J
    Med Sci Monit; 2015 Apr; 21():987-91. PubMed ID: 25841171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of nesfatin-1 are increased in gestational diabetes mellitus.
    Zhang Y; Lu JH; Zheng SY; Yan JH; Chen L; Liu X; Wu WZ; Wang F
    Gynecol Endocrinol; 2017 Aug; 33(8):621-624. PubMed ID: 28361552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study.
    Kim SH; Ahn MB; Cho WK; Cho KS; Jung MH; Suh BK
    Medicine (Baltimore); 2019 May; 98(19):e15460. PubMed ID: 31083178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice.
    Dong J; Xu H; Xu H; Wang PF; Cai GJ; Song HF; Wang CC; Dong ZT; Ju YJ; Jiang ZY
    PLoS One; 2013; 8(12):e83397. PubMed ID: 24391760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERUM NESFATIN-1 LEVEL IN HEALTHY SUBJECTS WITH WEIGHT-RELATED ABNORMALITIES AND NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES MELLITUS; A CASE-CONTROL STUDY.
    Mirakhor Samani S; Ghasemi H; Rezaei Bookani K; Shokouhi B
    Acta Endocrinol (Buchar); 2019; -5(1):69-73. PubMed ID: 31149062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesfatin-1 - as a diagnosis regulatory peptide in type 2 diabetes mellitus.
    Kadim BM; Hassan EA
    J Diabetes Metab Disord; 2022 Dec; 21(2):1369-1375. PubMed ID: 36404867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.
    Alotibi MN; Alnoury AM; Alhozali AM
    Saudi Med J; 2019 Jan; 40(1):19-25. PubMed ID: 30617376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METABOLIC AND HORMONAL FEATURES OF CHRONIC HEART FAILURE IN PERSONS WITH POST-INFARCTION CARDIOSCLEROSIS WITH TYPE 2 DIABETES MELLITUS AND OBESITY.
    Bilovol OM; Dunaeva IP; Kravchun PP
    Wiad Lek; 2022; 75(11 pt 2):2831-2834. PubMed ID: 36591775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
    Abaci A; Catli G; Anik A; Kume T; Bober E
    Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of circulating nesfatin-1, GSH and SOD on insulin secretion in the development of T2DM.
    Huang K; Liang Y; Wang K; Wu J; Luo H; Yi B
    Front Public Health; 2022; 10():882686. PubMed ID: 36045734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism.
    He S; He Y; Jin F; Liu Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25432. PubMed ID: 33847643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesfatin-1 ameliorates type-2 diabetes-associated reproductive dysfunction in male mice.
    Ranjan A; Choubey M; Yada T; Krishna A
    J Endocrinol Invest; 2020 Apr; 43(4):515-528. PubMed ID: 31691259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.
    Anwar GM; Yamamah G; Ibrahim A; El-Lebedy D; Farid TM; Mahmoud R
    Regul Pept; 2014 Jan; 188():21-4. PubMed ID: 24333832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
    Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
    Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.